205 related articles for article (PubMed ID: 31255879)
1. Type I interferon induced by DNA of nontypeable Haemophilus influenza modulates inflammatory cytokine profile to promote susceptibility to this bacterium.
Yang S; Yin Y; Xu W; Zhang X; Gao Y; Liao H; Hu X; Wang J; Wang H
Int Immunopharmacol; 2019 Sep; 74():105710. PubMed ID: 31255879
[TBL] [Abstract][Full Text] [Related]
2. Conserved nontypeable Haemophilus influenzae-derived TLR2-binding lipopeptides synergize with IFN-beta to increase cytokine production by resident murine and human alveolar macrophages.
Punturieri A; Copper P; Polak T; Christensen PJ; Curtis JL
J Immunol; 2006 Jul; 177(1):673-80. PubMed ID: 16785566
[TBL] [Abstract][Full Text] [Related]
3. The Pulmonary Extracellular Matrix Is a Bactericidal Barrier Against
Abdillahi SM; Tati R; Nordin SL; Baumgarten M; Hallgren O; Bjermer L; Erjefält J; Westergren-Thorsson G; Singh B; Riesbeck K; Mörgelin M
Front Immunol; 2018; 9():1988. PubMed ID: 30233584
[TBL] [Abstract][Full Text] [Related]
4. Nontypeable Haemophilus influenzae DNA stimulates type I interferon expression via STING signaling pathway.
Lu C; Zhang X; Ma C; Xu W; Gan L; Cui J; Yin Y; Wang H
Biochim Biophys Acta Mol Cell Res; 2018 Apr; 1865(4):665-673. PubMed ID: 29421524
[TBL] [Abstract][Full Text] [Related]
5. Steroid-induced Deficiency of Mucosal-associated Invariant T Cells in the Chronic Obstructive Pulmonary Disease Lung. Implications for Nontypeable Haemophilus influenzae Infection.
Hinks TS; Wallington JC; Williams AP; Djukanović R; Staples KJ; Wilkinson TM
Am J Respir Crit Care Med; 2016 Nov; 194(10):1208-1218. PubMed ID: 27115408
[TBL] [Abstract][Full Text] [Related]
6. Lung Surfactant Lipids Provide Immune Protection Against
García-Fojeda B; González-Carnicero Z; de Lorenzo A; Minutti CM; de Tapia L; Euba B; Iglesias-Ceacero A; Castillo-Lluva S; Garmendia J; Casals C
Front Immunol; 2019; 10():458. PubMed ID: 30936871
[TBL] [Abstract][Full Text] [Related]
7. Nontypeable Haemophilus influenzae induces COX-2 and PGE2 expression in lung epithelial cells via activation of p38 MAPK and NF-kappa B.
Xu F; Xu Z; Zhang R; Wu Z; Lim JH; Koga T; Li JD; Shen H
Respir Res; 2008 Jan; 9(1):16. PubMed ID: 18237405
[TBL] [Abstract][Full Text] [Related]
8. Calcium restores the macrophage response to nontypeable haemophilus influenzae in chronic obstructive pulmonary disease.
Provost KA; Smith M; Arold SP; Hava DL; Sethi S
Am J Respir Cell Mol Biol; 2015 Jun; 52(6):728-37. PubMed ID: 25338285
[TBL] [Abstract][Full Text] [Related]
9. Critical role of type 1 plasminogen activator inhibitor (PAI-1) in early host defense against nontypeable Haemophilus influenzae (NTHi) infection.
Lim JH; Woo CH; Li JD
Biochem Biophys Res Commun; 2011 Oct; 414(1):67-72. PubMed ID: 21945446
[TBL] [Abstract][Full Text] [Related]
10. Antibacterial Defense of Human Airway Epithelial Cells from Chronic Obstructive Pulmonary Disease Patients Induced by Acute Exposure to Nontypeable Haemophilus influenzae: Modulation by Cigarette Smoke.
Amatngalim GD; Schrumpf JA; Henic A; Dronkers E; Verhoosel RM; Ordonez SR; Haagsman HP; Fuentes ME; Sridhar S; Aarbiou J; Janssen RAJ; Lekkerkerker AN; Hiemstra PS
J Innate Immun; 2017; 9(4):359-374. PubMed ID: 28171878
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of interleukin-8 by novel small cytoplasmic molecules of nontypeable Haemophilus influenzae via p38 and extracellular signal-regulated kinase pathways.
Wang B; Cleary PP; Xu H; Li JD
Infect Immun; 2003 Oct; 71(10):5523-30. PubMed ID: 14500470
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol therapeutics combines both antimicrobial and immunomodulatory properties against respiratory infection by nontypeable Haemophilus influenzae.
Euba B; López-López N; Rodríguez-Arce I; Fernández-Calvet A; Barberán M; Caturla N; Martí S; Díez-Martínez R; Garmendia J
Sci Rep; 2017 Oct; 7(1):12860. PubMed ID: 29038519
[TBL] [Abstract][Full Text] [Related]
13. Resolvin D1 Dampens Pulmonary Inflammation and Promotes Clearance of Nontypeable Haemophilus influenzae.
Croasdell A; Lacy SH; Thatcher TH; Sime PJ; Phipps RP
J Immunol; 2016 Mar; 196(6):2742-52. PubMed ID: 26843331
[TBL] [Abstract][Full Text] [Related]
14. Understanding nontypeable Haemophilus influenzae and chronic obstructive pulmonary disease.
Alikhan MM; Lee FE
Curr Opin Pulm Med; 2014 Mar; 20(2):159-64. PubMed ID: 24441573
[TBL] [Abstract][Full Text] [Related]
15. Dectin-1 is expressed in human lung and mediates the proinflammatory immune response to nontypeable Haemophilus influenzae.
Heyl KA; Klassert TE; Heinrich A; Müller MM; Klaile E; Dienemann H; Grünewald C; Bals R; Singer BB; Slevogt H
mBio; 2014 Aug; 5(5):e01492-14. PubMed ID: 25161190
[TBL] [Abstract][Full Text] [Related]
16. Genome Expression Profiling-Based Identification and Administration Efficacy of Host-Directed Antimicrobial Drugs against Respiratory Infection by Nontypeable Haemophilus influenzae.
Euba B; Moleres J; Segura V; Viadas C; Morey P; Moranta D; Leiva J; de-Torres JP; Bengoechea JA; Garmendia J
Antimicrob Agents Chemother; 2015 Dec; 59(12):7581-92. PubMed ID: 26416856
[TBL] [Abstract][Full Text] [Related]
17. Lung T-cell responses to nontypeable Haemophilus influenzae in patients with chronic obstructive pulmonary disease.
King PT; Lim S; Pick A; Ngui J; Prodanovic Z; Downey W; Choong C; Kelman A; Baranyai E; Francis M; Moshinsky R; Bardin PG; Holmes PW; Holdsworth SR
J Allergy Clin Immunol; 2013 May; 131(5):1314-21.e14. PubMed ID: 23142009
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 18 participates in the early inflammatory response and bacterial clearance during pneumonia caused by nontypeable Haemophilus influenzae.
Wieland CW; Florquin S; van der Poll T
Infect Immun; 2007 Oct; 75(10):5068-72. PubMed ID: 17664259
[TBL] [Abstract][Full Text] [Related]
19. The pomegranate-derived peptide Pug-4 alleviates nontypeable
Jantaruk P; Roytrakul S; Sistayanarain A; Kunthalert D
PeerJ; 2024; 12():e16938. PubMed ID: 38406294
[TBL] [Abstract][Full Text] [Related]
20. The Interplay Between Immune Response and Bacterial Infection in COPD: Focus Upon Non-typeable
Su YC; Jalalvand F; Thegerström J; Riesbeck K
Front Immunol; 2018; 9():2530. PubMed ID: 30455693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
